ADAP
Adaptimmune Therapeutics plc - American Depositary Shares (ADAP)
$28
About Adaptimmune Therapeutics plc - American Depositary Shares (ADAP)
Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. Its clinical pipeline includes Afami-cel, Lete-cel, and ADP-A2M4CD8. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom.
Details
Daily high
$0.28
Daily low
$0.26
Price at open
$0.27
52 Week High
$1.48
52 Week Low
$0.20
Market cap
72.2M
Dividend yield
0.00%
Volume
388,857
Avg. volume
1.6M
P/E ratio
-1.02
Adaptimmune Therapeutics plc - American Depositary Shares News
Details
Daily high
$0.28
Daily low
$0.26
Price at open
$0.27
52 Week High
$1.48
52 Week Low
$0.20
Market cap
72.2M
Dividend yield
0.00%
Volume
388,857
Avg. volume
1.6M
P/E ratio
-1.02